ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis
Tabeajaichhalt / Pixabay

ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis

According to a story from Buzzfeed News, Stephen Hillenburg, the creator of the smash hit children's cartoon SpongeBob SquarePants has passed away at age 57. Last year, Hillenburg had revealed…

Continue Reading ICYMI: Creator of “SpongeBob SquarePants” Dies After Being Diagnosed With Amyotrophic Lateral Sclerosis
Data Looks Good For Synlogic’s Experimental Phenylketonuria Drug, And If You’re a Patient, You Can Get Involved
DarkoStojanovic / Pixabay

Data Looks Good For Synlogic’s Experimental Phenylketonuria Drug, And If You’re a Patient, You Can Get Involved

The biotechnology company Synlogic announced positive data from its most recent Phase 1/2a clinical trial of its experimental product SYNB1618. This trial did not test the therapeutic action of the…

Continue Reading Data Looks Good For Synlogic’s Experimental Phenylketonuria Drug, And If You’re a Patient, You Can Get Involved
Express Scripts Makes Diagnosis Easier with Second Opinion
Source: Pixabay

Express Scripts Makes Diagnosis Easier with Second Opinion

According to PRNewswire, Express Scripts announced a new program to benefit people living with rare diseases on May 31st. The program, called Second Opinion is part of the company’s larger…

Continue Reading Express Scripts Makes Diagnosis Easier with Second Opinion
Virginia Expands Medicaid Access to 400,000 Citizens, But What Does it Mean for Rare Patients?
source: pixabay.com

Virginia Expands Medicaid Access to 400,000 Citizens, But What Does it Mean for Rare Patients?

After years of resistance from the previously dominant Republican party, Virginia lawmakers were successfully able to pass a measure expanding Medicaid to nearly 400,000 more Virginians, according to the Washington…

Continue Reading Virginia Expands Medicaid Access to 400,000 Citizens, But What Does it Mean for Rare Patients?
New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.
source: pixabay.com

New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.

According to a story from globenewswire.com, the pharmaceutical companies Ultragenyx and Kyowa Kirin recently issued an announcement that the U.S. FDA has granted approval to their new treatment Crysvita (burosumab-twza).…

Continue Reading New Drug Gains Approval For Treating X-Linked Hypophosphatemia in the U.S.
The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy

According to a story from raredr.com, The U.S. Food and Drug Administration (FDA) has recently approved Hizentra as a maintenance therapy for patients with chronic inflammatory demyelinating polyneuropathy. Hizentra is…

Continue Reading The FDA Just Approved a New Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy
Celebrate a Holiday your Kidney will appreciate: World Kidney Month!
Source: Pixabay

Celebrate a Holiday your Kidney will appreciate: World Kidney Month!

Last week was World Kidney Day! And in fact, the whole month of March is kidney month - so there's no excuse to brush up on some key kidney facts…

Continue Reading Celebrate a Holiday your Kidney will appreciate: World Kidney Month!